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Normal human cellse human subgroup C adenovirus type 5 (Ad5) E1B 55 kDa protein can regulate the
activity and concentration of the cellular tumor suppressor, p53. However, the contribution(s) of these
functions of the E1B protein to viral reproduction remains unclear. To investigate this issue, we examined
properties of p53 in normal human cells infected by E1B mutant viruses that display defective entry into the
late phase or viral late mRNA export. The steady-state concentrations of p53 were signiﬁcantly higher in cells
infected by the E1B 55 kDa null mutant Hr6 or three mutants carrying small insertions in the E1B 55 kDa
protein coding sequence than in Ad5-infected cells. Nevertheless, none of the mutants induced apoptosis in
infected cells. Rather, the localization of p53 to E1B containing nuclear sites observed during infection by Ad5
was prevented by mutations that impair interaction of the E1B protein with p53 and/or with the E4 Orf6
protein. These results indicate that the E1B protein fulﬁlls an early function that correlates efﬁcient entry into
the late phase with the localization of E1B and p53 in the nucleus of Ad5-infected normal human cells.
© 2008 Elsevier Inc. All rights reserved.IntroductionThe human subgroup C adenoviral E1A, E1B and E4 early genes
encode proteins that exhibit transforming activity because they
disrupt host cell processes that regulate cell proliferation (Jones,
1990). The same gene products are also responsible for establishing
appropriate conditions in the infected cell for efﬁcient viral DNA
synthesis and production of viral progeny (Berk, 2006). During the
early phase of productive adenoviral infection, the E1A gene products
induce accumulation of the cellular tumor suppressor p53, and
apoptosis (Debbas and White, 1993; Lowe and Ruley, 1993; Zhang et
al., 2004). However, the E1B 19 and 55 kDa proteins can counter the
cytotoxic effects of increased p53 concentrations (Cuconati et al.,
2002; White, 2001). The E1B 55 kDa protein binds to the amino-
terminus of p53, tethering a repressor domain that inhibits transcrip-
tion from promoters that contain p53 target sequences (Martin and
Berk, 1998, 1999; Yew et al., 1994). Suppression of p53-dependent
transcription has also been described for the E4 Orf6 protein, which
can also bind to p53 (Dobner et al.,1996; Nevels et al., 1997). Moreover,
the E1B 55 kDa and E4 Orf6 proteins form a complex that can associate
with cellular proteins to form an infected cell-speciﬁc, cullin5-
containing E3 ubiquitin ligase that polyubiquitinylates and stimulates
proteasomal degradation of p53 (Harada et al., 2002; Querido et al.,
2001; Sarnow et al., 1984; Woo and Berk, 2007).vaca, Morelos 62209, México.
.
l rights reserved.In infected cell nuclei, the E1B 55 kDa and E4 Orf6 proteins
colocalize to the peripheral zones of speciﬁc nuclear microenviron-
ments where viral DNA replication, transcription of viral late genes
and the initial posttranscriptional processing of viral late mRNAs take
place (Aspegren et al., 1998; Bridge et al., 1995; Ornelles and Shenk,
1991; Pombo et al., 1994; Puvion-Dutilleul et al., 1992). Mutations that
reduce binding of the E1B 55 kDa (E1B) to the E4 Orf6 protein result in
altered localization of E1B, and inefﬁcient export of viral late mRNAs
(Gonzalez and Flint, 2002; Ornelles and Shenk, 1991; Rubenwolf et al.,
1997), correlating efﬁcient viral late mRNA export with the organiza-
tion of infected cell nuclei.
Replication of mutants null for production of the E1B protein is
temperature dependent, cell cycle restricted, and varies with the
identity of the cell used as host (reviewed in Dix et al., 2001; Goodrum
and Ornelles, 1997, 1998, 1999; Harada and Berk, 1999; Ho et al., 1982).
While the ﬁrst two properties have been ascribed to inefﬁcient late
mRNA export and late protein synthesis in HeLa and other
transformed human cell lines (Goodrum and Ornelles, 1998; Harada
and Berk, 1999; Ho et al., 1982; Leppard and Shenk, 1989; Royds et al.,
2006; Shen et al., 2001; Williams et al., 1986), the molecular
mechanisms that are responsible for selective replication in speciﬁc
cell types are not fully understood (Bischoff et al., 1996; Dix et al.,
2001; Edwards et al., 2002; Hann and Balmain, 2003; Harada and
Berk, 1999; Rothmann et al., 1998; Turnell et al., 1999). Indeed,
although considerable effort has been devoted to the study and
development of viruses that can selectively replicate in, and kill tumor
cells efﬁciently (Dobbelstein, 2004; Everts and van der Poel, 2005;
Lichtenstein and Wold, 2004; O'Shea, 2005), the basis for selective
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been elucidated. As the E1B protein can inactivate p53, it was initially
hypothesized that these mutants would not replicate efﬁciently in the
presence of wild-type p53 (Bischoff et al., 1996). One such mutant,
ONYX-015, initially called dl1520 (Barker and Berk, 1987), has shown
promising results in early clinical trials as an oncolytic agent (O'Shea,
2005) (reviewed in McCormick, 2003). Nevertheless selective replica-
tion of ONYX-015 does not correlate with the p53 status of the cells
used as host (Cherubini, et al., 2006; Goodrum and Ornelles, 1998;
Harada and Berk, 1999; Rothmann et al., 1998; Turnell et al., 1999).
Furthermore, it has been reported that p53 may be required for
efﬁcient viral replication (Hall et al., 1998; Royds et al., 2006).
The p53 tumor suppressor is known to act as a master regulator of
cell cycle progression and apoptosis in response to DNA damage and
other types of stress (reviewed in Gostissa et al., 2003; Harris, 2005).
Its activities are governed by a variety of mechanisms that include
regulated synthesis and translation of p53 mRNA, and post-transla-
tional modiﬁcations of the protein (reviewed in Oren, 1999). The roles
of p53 in induction of apoptosis or cell cycle arrest in response to
genotoxic and other types of stress arewell established, and much has
been learnt about the mechanisms by which the activities of p53 are
prevented by viral proteins in transformed cells (reviewed in Harris,
2005). However, the functions of p53, and of the mechanisms by
which the E1B protein blocks the accumulation or activity of this
cellular protein during productive infection by adenoviruses, are not
fully understood. Most studies to investigate the effects of Ad5
infection on p53 in productively infected cells have used established
cell lines that either do not contain wild-type p53 or harbor other
abnormal genotypic traits (Bischoff et al., 1996; Goodrum and
Ornelles, 1997, 1998; Hall et al., 1998; Harada and Berk, 1999; Heise
et al., 1997; Hobom and Dobbelstein, 2004; Rothmann et al., 1998;
Steegenga et al., 1998) (reviewed in Dix et al., 2001; Dobbelstein,
2004). We previously reported that infection of HFF with E1B mutants
(H224, Hr6) that either do not express E1B or synthesize an E1B that is
impaired for p53 binding resulted in inefﬁcient DNA replication,
implicating an early function of the E1B protein that is independent of
selective viral late mRNA export and that could correlate with p53
binding. To address this issue, we have performed experiments
designed to examine the impact of the interplay between the E1B
55 kDa, E4 Orf6 and p53 proteins on regulation of p53 in the context of
a productive adenovirus infection of primary human cells.
Results
Effects of Ad5 and E1B mutant virus infection on the accumulation of the
p53 protein
As discussed in the Introduction, the E1B 55 kDa protein can both
associate with the cellular p53 tumor suppressor to repress p53-
dependent transcription and, in conjunction with the viral E4 Orf6
protein, induce p53 degradation. Although these activities are
required for E1B-dependent transformation, their contributions to
productive adenoviral replication are not well understood. WeFig.1. Accumulation of p53 in HFFs infectedwith Ad5 and E1Bmutants. HFFs weremock-infec
were analyzed by immunoblotting using anti-p53 MAb 421 (a and b) and an anti-tubulin Mrecently observed that infection of normal human cells with the
E1B 55 kDa null mutant Hr6, or an insertion mutant that affects
binding of the E1B to p53 (H224) display defective viral DNA
synthesis (Gonzalez et al., 2006). We therefore wished to determine
whether such defects might be a consequence of effects of the p53
protein, and ﬁrst examined the steady-state concentrations of this
cellular protein in Ad5 and Hr6-infected cells. Soluble extracts of
infected HFFs were prepared and analyzed by immunoblotting as
described in the Materials and methods section. Ad5 infection
induced a reduction in the low concentration of p53 detected in
HFFs, but not until 30 h pi, that is, late in infection (Fig. 1a). As
anticipated, signiﬁcantly higher concentration of the cellular protein
accumulated in Hr6-infected cells.
We also examined p53 concentration in cells infected with several
previously characterized mutants carrying small insertions in the E1B
coding sequence (Yew et al., 1990). The A143 mutation impairs
binding of the E1B to the E4 Orf6 protein (Rubenwolf et al., 1997), and
induces a severe defect in export of viral late mRNA in HFFs (Gonzalez
et al., 2006). The H224 mutation results in inhibition of viral DNA
synthesis in HFFs, and reduced interaction of the E1B protein with
both the E4 Orf6 and p53 proteins (Gonzalez et al., 2006; Rubenwolf et
al., 1997; Yew et al., 1990). The H354 insertion results in lower binding
to the cellular E1B-AP5 protein (Gabler et al., 1998; Kao et al., 1990),
which has recently been reported to interact with the p53 protein
(Barral et al., 2005). A higher concentration of p53 was observed in
cells infected by all the E1B mutants than detected in Ad5 infected
cells (Fig. 1b), indicating that degradation of p53 was impaired by each
of the mutations, as well as by the absence of the E1B protein in Hr6-
infected cells. This effect of the mutations on accumulation of p53 was
signiﬁcantly more pronounced late in infection.
The E1B 55 kDa protein is not required to protect HFFs against induction
of apoptosis
The accumulation of the cellular p53 protein in HFFs infected by
the E1B mutant viruses (Fig. 1) could result in induction of apoptosis
(see Introduction), which might contribute to inefﬁcient viral
replication. To investigate this possibility, apoptosis was examined
in HFFs infected by Ad5 and the mutants described in the previous
section. In these experiments, we used several different methods to
assess induction of apoptosis, including FACS analysis of infected cells
stained with ﬂuorescent annexin V and propidium iodide and assays
for cleavage of poly (ADP-ribose) polymerase (Parp).
Analysis of phosphatidylserine exposure in infected cells by FACS
showed relatively small increases in the number of annexin V
positive cells in Ad5-infected cells when compared to mock (from 8%
to 14%) or in the E1B mutants-infected cells relative to Ad5 (from
14% to 22%), despite considerably higher intracellular concentrations
of p53 in the E1B mutants-infected cells (Fig. 2). Furthermore,
virtually no speciﬁc cleavage of Parp could be detected in HFFs
infected by Hr6 (or Ad5), although efﬁcient cleavage (i.e. induction of
apoptosis) was observed in control cells treated with TNF-α and
cycloheximide (Fig. 2b). We have also observed no signiﬁcantted or infectedwith Ad5 or themutants listed for the periods indicated. Total cell lysates
Ab as internal control (b) as described in Materials and methods.
Fig. 2. Apoptosis is not induced in HFFs infected with Ad5 or the E1B mutants. (a) HFFs infected with 30 PFU/cell of Ad5, the E1B insertion mutants, or Hr6, or mock-infected, were
treated with the Annexin V-FLUOS (Roche) and apoptotic cells were quantiﬁed as described in Materials and methods. Results represent the average of at least two independent
experiments, and all measurements were performed at least in duplicate. (b) Proliferating HFFs were infected with Ad5 or Hr6, or mock-infected and harvested after the periods
indicated. Total cell lysates were examined by immunoblotting with an anti-Parp antibody. The arrow at the right indicates the Parp-cleavage product characteristic of apoptotic cells
that is present in HFFs exposed to TNF-α and cycloheximide.
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caspase speciﬁc antibody (not shown). The failure to detect a
signiﬁcant increase in apoptotic cells in Hr6-infected cells by very
different assays indicates that this cellular response is efﬁciently
inhibited in the absence of the E1B 55 kDa protein, and in cells that
contain high concentrations of p53.
Binding of E1B 55 kDa to E4 Orf6 or p53 leads to altered intracellular
localization of p53 in HFFs
One of the mechanisms of p53 activation requires relocalization of
p53 by Pml proteins to speciﬁc intranuclear sites, termed nuclear
bodies (NB) or nuclear domains 10 (ND10), a process that is essential
for both transcriptional regulation of p53-responsive genes and
activation of the apoptotic program (Gostissa et al., 2003; Pearson,
2001; Takahashi et al., 2004). To assess the role of the E1B 55 kDa
protein in the subcellular reorganization of p53 during adenovirus
infection, we analyzed the effects of infection with Ad5 and the E1B
mutants on p53 localization. As previously reported, the kinetics of
Ad5 replication in HFF cells are delayed and entry into the late phase
occurs at approximately 24 h after infection (Gonzalez et al., 2006).
HFFs grown to approximately 90% conﬂuence were initially infected
with Ad5, the E1B-null mutant Hr6 or mock-infected, and the
intracellular distributions of E1B and p53 were examined by
immunoﬂuorescence, at times after infection that correspond to the
early and late phases (20 h and 32 h, respectively), as described in the
Materials and methods section. The E1B protein distribution in Ad5
infected HFFs was similar to that described previously in HeLa cells(Ornelles and Shenk, 1991), where it was present in the nucleus of
most cells as diffuse homogeneous staining and in numerous small
specks and ring-like structures. However, two types of ring-like
structures that differed in size and number were apparent in HFFs by
20 h after infection: small ring-like structures similar to the peripheral
zones of replication centers at which E1B, DBP and E4 Orf6 have been
previously localized (Gonzalez and Flint, 2002; Ornelles and Shenk,
1991), and a smaller number, of larger ring-like structures (Fig. 3,
panels a and c). By the late phase, at 32 h after infection, a more
pronounced localization to both types of rings was observed in most
cells (Fig. 3, panels d and f). As expected, no E1B was detected in cells
infected with Hr6, or that were mock-infected (Fig. 4).
As the intracellular localization of p53 in Ad5-infected HFFs has not
been reported, we initially examined its distribution in mock-infected
cells (Fig. 4). The protein was distributed throughout the cytoplasm in
a ﬁne reticular structure, similar to the cytoskeletal ﬁbrillar actin
network that has been suggested for the cytoplasmic localization of
p53 (Katsumoto et al., 1995; Laín et al., 1999; Metcalfe et al., 1999).
Within the nucleus, denser staining was seen, and appeared as a mesh
or interconnected network.
Signiﬁcant alterations in p53 localization were observed in Hr6-
infected cells, that is, in the absence of the E1B 55 kDa protein. Hr6
infection caused a sharp decrease in the concentration of cytoplasmic
p53 by 20 h after infection, when most of the protein localized to the
nucleus. The nuclear concentration of p53 remained high at 32 h after
infection (Fig. 4). These observations indicate that infection of HFFs by
Ad5 induces alterations in the intracellular localization of p53 that are
independent of the E1B 55 kDa protein.
Fig. 3. Intracellular localization of E1B 55 kDa and p53 proteins in Ad-infected HFFs. The intracellular distribution of E1B and p53 was analyzed by immunoﬂuorescence and confocal
microscopy at 20 h and 32 h after infection. Monoclonal antibodies 2A6 and 421were directly labeled with Alexa-488 and Alexa-594, respectively, and used simultaneously. The small
and large ring-like structures described in the text are indicated by white arrowheads and arrows, respectively. Cells were analyzed using a 63× water immersion objective. For closer
inspection images were magniﬁed 2×.
342 F.M. Cardoso et al. / Virology 378 (2008) 339–346The cytoplasmic population of p53 also decreased by 20 h after Ad5
infection, but in contrast to Hr6-infected cells, by 32 h the cytopathic
effects were advanced, and a cytoplasmic p53-associated signal could
be seen in disorganized, bleb-like structures (Fig. 3, panel e).Fig. 4. Nuclear accumulation of p53 in HFFs infected with the E1B-null mutant Hr6.
immunoﬂuorescence with the 421 and 2A6 MAbs as described in Materials and methods. T
infected with Hr6 at 32 h. Cells were analyzed using a 63× water immersion objective. ForFurthermore, by 20 h after Ad5 infection, the p53 signal was
concentrated inside and around spherical nuclear structures, showing
a higher density at their periphery, where it displayed a partial but
clear colocalization with the rings formed by the E1B protein (Fig. 3,Cells were infected with Hr6 at 30 PFU/cell or mock-infected, and processed for
he arrows indicate nuclear structures devoid of p53 in mock-infected cells and in cells
closer inspection images were ampliﬁed 2× as indicated.
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was more pronounced at 32 h after Ad5 infection, when the nuclear
organization of the protein was clearly associated with that of E1B, as
the large rings formed by E1B were the sites of highest p53
accumulation: protein present inside these globular structures was
most concentrated at the periphery, coinciding with the highest E1B
protein concentration (Fig. 3, panels d–f). A similar pattern of
distribution has been observed for p53 in Ad5-infected HFF cells
using a different anti-p53 antibody (MAb 1801), indicating that the
signal observed is speciﬁc for p53 (Supplementary Fig. 1). These dataFig. 5. Effect of E1B mutations, on the subcellular localization of p53. The localization of E1
infection as described in Materials and methods: A143, panels a–f; H224, panels g–l; H354, p
white arrowheads and arrows, respectively.indicate, that although the initial re-distribution of p53 to the cell
nucleus induced by Ad5 infection does not depend on the E1B 55 kDa
protein, the relocalization of p53 to both types of ring-like structures
is induced only when this viral protein is made. Furthermore the p53
protein colocalizes with the E1B protein within the nucleus during
both the early and late phases of infection.
We next examined the effects of the E1B insertion mutants on the
intracellular locations of the viral and the p53 proteins. By 20 h after
infectionwith the A143 or H224 mutants, most of the E1B proteinwas
present in nuclei, where its distributionwas more diffuse than in Ad5-B and p53 was analyzed in HFFs infected with the E1B mutants at 20 h and 32 h after
anels m–r. The small and large ring-like structures described in the text are indicated by
344 F.M. Cardoso et al. / Virology 378 (2008) 339–346infected cells, with few cells showing small circular structures (Fig. 5,
panels b and h). Moreover, although the larger ring-like structures
were present in some cells, they did not appear as clearly deﬁned as in
Ad5-infected cells. The p53 protein was associated with the large dot-
like structures in some cells, but its distribution appeared diffuse and
homogeneous in the nucleus of A143-infected cells (compare Figs. 3 to
5, panels a–c), and not as well deﬁned, nor as obviously inter-
connected, in the nucleus of H224-infected cells, as in Ad5-infected
cells (Fig. 5, panels g–i). Moreover, by 32 h after infection fewer cells
displayed colocalization of E1B and p53 in ring-like structures (Fig. 5,
panels d–f and j–l). In contrast to A143 and H224, the altered E1B
protein synthesized in H354-infected HFFs displayed a localization
pattern in ring-like structures similar to that of the wild-type protein
(Fig. 5, panels m–o). Furthermore, only cells infected by H354
displayed the temporal alterations in the distribution of p53
characteristic of Ad5-infected cells (Figs. 5m–r). For example, forma-
tion of structures with the p53 protein concentrated in globules was
observed only in cells infected by Ad5 or H354. These data indicate
that the relocalization of p53 induced by Ad5 infection of HFFs
requires binding of the E1B 55 kDa protein to both the E4 Orf6 and p53
proteins.
Discussion
Adenovirus mutants that either do not produce the E1B 55 kDa
protein or synthesize altered proteins display defects in late phase
functions such as inefﬁcient viral late mRNA export (see the
Introduction). We recently found that this viral protein also fulﬁlls
an important early function during infection of normal human cells, as
viral DNA synthesis is less efﬁcient in cells infected by Hr6 than in
Ad5-infected cells (Gonzalez et al., 2006).
Inefﬁcient viral DNA synthesis cannot be correlated with increased
accumulation of p53 in infected cells: the greatest increases in p53
concentrationwere observed during the late phase in cells infected by
the mutant viruses. Furthermore, all the mutations examined here
resulted in substantial accumulation of p53 (Fig. 1), even though viral
DNA synthesis is defective only in cells infected by Hr6 and H224
(Gonzalez et al., 2006). The A143 mutation inhibits binding of the E1B
55 kDa to the E4 Orf6 protein (Rubenwolf et al., 1997), whereas the
H224 insertion results in less efﬁcient interaction of the E1B protein
with p53 and E4 Orf6 (Gabler et al., 1998; Kao et al., 1990; Rubenwolf
et al., 1997). The interaction of E1B with both E4 Orf6 and p53 is
required for targeting of p53 for degradation by a cullin5-containing
ubiquitin ligase (Harada et al., 2002; Liu et al., 2005; Querido et al.,
2001). This property accounts for the accumulation of p53 in cells
infected by A143 and H224. An unexpected observation was that the
H354 mutant, which directs the synthesis of an E1B protein that
interacts efﬁciently with E4 Orf6 and p53, also failed to induce p53
degradation. As the H354 insertion decreased binding of the viral
protein to E1B-AP5 (Gabler et al., 1998), it is possible that p53
degradation also requires efﬁcient binding of E1B to AP5, which has
been reported to associate with p53 (Barral et al., 2005).
Accumulation of p53 can induce apoptosis, and it has been
generally assumed that inhibition of p53-dependent activation of
pro-apoptotic signals by the E1B 55 kDa protein facilitates adenovirus
replication (Debbas and White, 1993; White and Cipriani, 1990).
However, none of the E1B mutations resulted in levels of phospha-
tidylserine exposure or Parp cleavage that were signiﬁcantly higher
than those observed in Ad5- or mock-infected cells (Fig. 2). We
therefore conclude that they do not induce apoptosis, despite high
intracellular concentration of p53 in all mutant virus-infected cells.
This conclusion is consistent with the observation that high
concentrations of p53 did not result in apoptosis in ONYX-015-
infected small airway epithelial cells (O'Shea et al., 2004). Moreover,
we also observed that complete degradation of p53 is not attained in
Ad5-infected HFFs, in agreement with previous reports (Royds et al.,2006; Yew and Berk, 1992), indicating that regulation of the activity of
p53 is likely to be achieved by additional processes.
The activities of p53 are controlled by multiple mechanisms,
including various post-translational modiﬁcations, interactions with
other proteins, and recruitment to different cellular compartments
(see the Introduction). One important mechanism depends on the Pml
proteins, which recruit p53 to NBs in response to a variety of stress
stimuli (Pearson et al., 2000), reviewed in (Fogal, et al., 2000; Gostissa
et al., 2003; Guo et al., 2000). Indeed, such post-translational
modiﬁcations of p53 as acetylation, phosphorylation and deubiquiti-
nation are mediated by enzymes that are present in Pml-containing-
NBs including CBP/p300 (histone acetyl transferases), HIPK2 (a p53
kinase), and HAUSP (a p53 deubiquitinase). It has therefore been
proposed that these structures act as mini-factories for p53 post-
translational modiﬁcation, to which p53 is recruited in response to
different forms of stress, and that localization of p53 to speciﬁc
nuclear structures is essential for its function as a regulator of
transcription and cell cycle arrest or apoptosis (reviewed in Bernardi,
2003; Gostissa et al., 2003).
A characteristic feature of adenovirus-infected cells is the forma-
tion of infected cell-speciﬁc, nuclear structures with the concomitant
relocalization of several cellular components. The E1A proteins, which
bind to Rb and p300 to induce stabilization of p53 (Querido et al.,
1997), are found with the viral E4 Orf3 protein in ring-like and ﬁbrous
structures that contain cellular Pml proteins (Carvalho et al., 1995).
The E4 Orf3 protein induces reorganization of Pml to form these
structures (Doucas et al., 1996; Hoppe et al., 2006; Leppard and
Everett, 1999; Stracker et al., 2002), and in Ad5-infected HFF the PML
ﬁbers appear to colocalize with p53 (unpublished observations). The
E4 Orf3 is also required for relocalization of components of the cellular
Mre11–Rad50–Nbs1 complex and efﬁcient formation of viral DNA
replication centers (Doucas et al., 1996; Evans and Hearing, 2005).
Binding of the E1B 55 kDa protein to E4 Orf3 and E4 Orf6 is needed for
proper localization of E1B to DBP and E4 Orf6-containing replication
centers (Gonzalez and Flint, 2002; Leppard and Everett, 1999;
Lethbridge et al., 2003; Ornelles and Shenk, 1991). We now
demonstrate that the intracellular distribution of p53 is also altered
following Ad5 infection. This protein accumulates in the nucleus of
infected cells in the absence of the E1B protein (Fig. 4). However,
globular structures containing p53 are formed efﬁciently only in
infected cells that contain an E1B 55 kDa protein that is able to bind to
p53 and E4 Orf6, namely in Ad5- and H354-infected cells (Figs. 3 and
5). As these structures appear before initiation of viral DNA synthesis,
we conclude that an early function of the E1B 55 kDa protein in
normal host cells is relocalization of the p53 tumor suppressor.
It has been proposed that all the functions of the E1B 55 kDa
protein depend on its ability to associate with, and activate, a high
molecular weight ubiquitin protein ligase that assembles in aggre-
somes and induces proteasomal degradation of p53 and the Mre11
protein (Araujo et al., 2005; Liu et al., 2005; Woo and Berk, 2007). A
dominant negative derivative of cullin 5 inhibited such degradation, as
well as induction of selective export of viral late mRNA (Woo and Berk,
2007). In our experiments, we did not detect a perinuclear, E1B
protein-containing structure characteristic of the aggresome in Ad5-
infected HFFs. This failure is likely to be due to the severe cytopathic
effects induced in HFFs at the late times after Ad5 infection that
correspond to those at which aggresomes containing viral proteins
can be detected in HeLa cells (Araujo et al., 2005). It will therefore be
of interest to determine whether this structure can be observed at
later time points in primary cells infected at lower multiplicity.
Nevertheless, we have identiﬁed an early function of the E1B 55 kDa
protein that appears to be unrelated to formation of the infected cell-
speciﬁc ubiquitin ligase complex: formation of this complex (Querido
et al., 2001;Woo and Berk, 2007), but not efﬁcient viral DNA synthesis
(Gonzalez et al., 2006), requires binding of the E1B to the viral E4 Orf6
protein.
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Cells and viruses
293 and human foreskin ﬁbroblast (HFF) cells were grown as
monolayer cultures in Dulbecco's modiﬁed Eagle's medium supple-
mentedwith 5% and 10% fetal calf serum, respectively. The E1Bmutant
viruses A143, H224 and H354, which carry linker insertions in a hybrid
Ad2/Ad5 E1B gene, were generously provided by A. Berk (Yew et al.,
1990). The Ad5mutant Hr6, which carries a frameshift mutation in the
E1B 55 kDa coding sequence, was described previously (Harrison et
al., 1977). Ad5 (wild-type 300) and the E1B mutants were propagated
in monolayers of HeLa and 293 cells, respectively. Viruses were titered
by plaque assay on 293 cells as described (Williams, 1973), and a
multiplicity of infection of 30 PFU per cell was used in all experiments.
Steady-state concentrations of the cellular p53 protein
HFF cells at approximately 75–90% conﬂuence were infected with
Ad5 or the E1Bmutants at 30 PFU/cell. For immunoblotting, cells were
harvested at the times after infection indicated, washed with
phosphate-buffered saline (PBS), and extracted with 25 mM Tris–
HCl, pH 8.0, containing 50 mM NaCl, 0.5% (w/v) sodium deoxycholate,
0.5% (v/v) Nonidet P-40 (NP-40) and 1 mM phenylmethylsulfonyl
ﬂuoride for 30 min at 4 °C. Cell debris was removed by centrifugation
at 10,000 ×g at 4 °C for 5 min. The extracts were analyzed by sodium
dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis and immu-
noblotting as described previously (Gonzalez and Flint, 2002). The p53
proteinwas detectedwith themonoclonal antibody 421 (Harlow et al.,
1981); an anti-tubulin MAb (Sigma) was used as internal control.
Apoptosis assays
To assay for phosphatidylserine exposure and membrane perme-
ability to propidium iodide, the annexin V-FLUOS system (Roche) was
used according to the manufacturer's protocol. HFFs mock-infected or
infected with Ad5 or E1B mutants were harvested 16 h after infection
by the addition of phosphate-buffered saline (PBS) containing 5 mM
EDTA. After cells were detached from the plates, ice-cold PBS
containing 10 mM CaCl2 was added, and the cells were centrifuged at
200 ×g. The supernatant was discarded and cells were resuspended in
HEPES buffer containing FITC coupled annexin V and propidium iodide
and FITC positive cells were quantiﬁed by ﬂow cytometry using a
FACSCalibur System (Becton Dickinson). Results represent the average
of at least two independent experiments, and all measurements were
performed at least in duplicate. To assay for cleavage of poly (ADP-
ribose) polymerase (Parp), HFFs were infected with Ad5 or Hr6, or
mock-infected. At the times indicated cells were harvested, washed
with PBS and incubated with 20 mM Tris–HCl, pH 7.5 containing
150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 0.5% NP40,
2.5 mM sodium pyrophosphate, 1 mM β-glycerol phosphate, 1 mM
Na3VO4,1mMPMSF, 2 μg/ml leupeptin, and 1 μg/ml antipain on ice for
20 min. Lysates were sonicated brieﬂy, centrifuged at 12,000 ×g at 4 °C
for 10 min and analyzed by immunoblotting using anti-cleaved Parp
(Asp214) 19F4 mouse monoclonal antibody (Cell Signaling). HFFs
incubated with TNF (1 ng/ml) and cycloheximide (10 μg/ml) for 4 h
were used as positive controls.
Immunoﬂuorescence
HFFs grown on coverslips to approximately 90% conﬂuence were
mock-infected, or infected with Ad5 or E1B mutant viruses. At 20 and
32 h after infection (corresponding to early and late times of infection,
respectively), the cells were processed for immunoﬂuorescence as
described previously (Gonzalez and Flint, 2002). Treated cells were
incubated simultaneously with puriﬁed anti-p53 421 IgG coupled toAlexa-Fluor 594, and puriﬁed anti-E1B 55 kDa 2A6 IgG coupled to
Alexa-Flour 488 (Molecular Probes), both prepared and puriﬁed
according to the manufacturer's protocol. The coverslips were
mounted on glass slides in Aqua Polymount (Polysciences Inc.), and
samples were examined by confocal microscopy as described
previously (Gonzalez and Flint, 2002). Images were organized using
Adobe Photoshop 7.0.
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